CA Stock MarketDetailed Quotes

AQS Aequus Pharmaceuticals Inc

Watchlist

0.015
0.0000.00%

15min DelayTrading Nov 6 16:00 ET

1.99MMarket Cap-1000P/E (TTM)

Aequus Pharmaceuticals Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

--242.04K

-31.87%170.2K

-85.34%112.02K

-89.55%249.82K

--249.82K

-73.51%764.31K

-61.80%1.39M

-32.94%2.24M

39.14%2.39M

-Cash and cash equivalents

--242.04K

-31.87%170.2K

-85.34%112.02K

-89.55%249.82K

--249.82K

-73.51%764.31K

-61.80%1.39M

-32.94%2.24M

39.14%2.39M

Receivables

--36.13K

-89.78%31.69K

-74.60%69.82K

-67.05%310.1K

--310.1K

-59.06%274.9K

-53.27%296.59K

-45.22%265.84K

20.73%941.08K

-Accounts receivable

--25.71K

-89.78%31.69K

-74.60%69.82K

-67.05%310.1K

--310.1K

-59.06%274.9K

-53.27%296.59K

-45.22%265.84K

20.73%941.08K

-Taxes receivable

--10.42K

----

Inventory

--77.44K

31.89%123.75K

41.69%184.35K

-32.90%93.82K

--93.82K

-11.79%130.11K

57.56%155.75K

18.63%129.71K

13.38%139.83K

Prepaid assets

--74.35K

-68.09%65.13K

11.67%76.21K

169.84%204.11K

--204.11K

-7.85%68.24K

-67.96%41.54K

-17.99%147.52K

-48.44%75.64K

Restricted cash

--44.85K

0.00%44.85K

--44.85K

----

--44.85K

Total current assets

--474.81K

-51.74%435.61K

-62.00%487.26K

-74.88%902.69K

--902.69K

-66.06%1.28M

-58.15%1.88M

-31.27%2.83M

29.79%3.59M

Non current assets

Net PPE

--617.53K

-17.52%650.61K

-16.88%684.53K

225.54%788.77K

--788.77K

201.03%823.59K

-41.11%178.96K

-36.96%210.63K

-33.85%242.3K

-Gross PPE

--1.27M

0.00%1.31M

2.81%1.31M

106.98%1.31M

--1.31M

88.71%1.27M

-11.04%598.11K

-10.51%599.84K

-6.18%632.17K

-Accumulated depreciation

---647.58K

-26.59%-657.86K

-38.93%-623.94K

-33.30%-519.7K

---519.7K

-12.05%-449.09K

-13.76%-419.15K

-15.78%-389.21K

-26.79%-389.87K

Non current note receivables

----

10.80%566.76K

--528.91K

--509.26K

--512.84K

Total non current assets

--617.53K

-17.52%650.61K

-50.77%684.53K

4.45%788.77K

--788.77K

67.54%1.39M

105.90%707.87K

94.95%719.89K

106.16%755.14K

Total assets

--1.09M

-35.78%1.09M

-56.16%1.17M

-61.10%1.69M

--1.69M

-42.01%2.67M

-46.48%2.59M

-20.87%3.55M

38.71%4.35M

Liabilities

Current liabilities

Current debt and capital lease obligation

--5.12M

114.45%4.48M

61.34%3.48M

0.52%2.09M

--2.09M

6.69%2.15M

1,344.38%2.15M

1,343.54%2.14M

1,311.87%2.08M

-Current debt

--5.01M

118.50%4.37M

68.50%3.37M

3.77%2M

--2M

7.01%2M

--2M

--1.99M

--1.93M

-Current capital lease obligation

--113.79K

23.61%110.19K

-31.63%105.26K

-40.92%89.14K

--89.14K

2.66%153.95K

2.47%152.72K

2.48%151.8K

2.50%150.88K

Payables

--338.79K

209.95%274.23K

325.35%495.57K

-43.69%88.48K

--88.48K

-35.27%116.51K

-58.31%95.8K

18.34%278.28K

-2.34%157.11K

-accounts payable

--338.79K

209.95%274.23K

325.35%495.57K

-43.69%88.48K

--88.48K

-35.27%116.51K

-58.31%95.8K

18.34%278.28K

-2.34%157.11K

Current accrued expenses

--29.06K

-78.98%42.06K

99.20%175.54K

-9.72%200.11K

--200.11K

-52.95%88.12K

169.25%167.15K

33.25%168.18K

190.69%221.67K

Current liabilities

--5.49M

101.73%4.8M

75.80%4.15M

-3.23%2.38M

--2.38M

-1.16%2.36M

447.87%2.42M

407.29%2.58M

539.32%2.46M

Non current liabilities

Long term debt and capital lease obligation

--553.37K

-15.88%583.59K

-9.70%612.23K

580.29%693.78K

--693.78K

408.90%677.96K

-98.17%36.05K

-96.43%69.39K

-95.31%101.98K

-Long term debt

----

15.00%28.96K

-98.47%27.96K

-98.48%27K

-98.68%26.09K

-Long term capital lease obligation

--553.37K

-15.88%583.59K

-5.67%612.23K

814.13%693.78K

--693.78K

500.72%649K

-94.18%8.09K

-75.00%42.38K

-61.91%75.9K

Total non current liabilities

--553.37K

-15.88%583.59K

-9.70%612.23K

580.29%693.78K

--693.78K

408.90%677.96K

-98.17%36.05K

-96.43%69.39K

-95.31%101.98K

Total liabilities

--6.04M

75.16%5.38M

56.71%4.76M

20.03%3.07M

--3.07M

20.53%3.04M

1.80%2.45M

8.29%2.65M

-0.07%2.56M

Shareholders'equity

Share capital

--23.99M

0.00%23.99M

--23.99M

0.00%23.99M

3.56%23.99M

13.31%23.99M

-common stock

--23.99M

0.00%23.99M

--23.99M

0.00%23.99M

3.56%23.99M

13.31%23.99M

Retained earnings

---33.35M

-9.98%-32.68M

-11.39%-31.97M

-12.11%-29.72M

---29.72M

-9.61%-28.7M

-9.29%-28.2M

-8.31%-27.43M

-7.33%-26.51M

Gains losses not affecting retained earnings

--4.41M

1.17%4.4M

1.07%4.39M

0.95%4.35M

--4.35M

1.49%4.34M

2.53%4.34M

3.37%4.33M

5.02%4.31M

Total stockholders'equity

---4.95M

-211.14%-4.29M

-885.96%-3.59M

-177.14%-1.38M

---1.38M

-117.41%-363.79K

-94.40%135.93K

-56.08%891.83K

211.71%1.79M

Total equity

---4.95M

-211.14%-4.29M

-885.96%-3.59M

-177.14%-1.38M

---1.38M

-117.41%-363.79K

-94.40%135.93K

-56.08%891.83K

211.71%1.79M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	--242.04K	-31.87%170.2K	-31.87%170.2K	-85.34%112.02K	-89.55%249.82K	--249.82K	-73.51%764.31K	-61.80%1.39M	-32.94%2.24M	39.14%2.39M
-Cash and cash equivalents	--242.04K	-31.87%170.2K	-31.87%170.2K	-85.34%112.02K	-89.55%249.82K	--249.82K	-73.51%764.31K	-61.80%1.39M	-32.94%2.24M	39.14%2.39M
Receivables	--36.13K	-89.78%31.69K	-89.78%31.69K	-74.60%69.82K	-67.05%310.1K	--310.1K	-59.06%274.9K	-53.27%296.59K	-45.22%265.84K	20.73%941.08K
-Accounts receivable	--25.71K	-89.78%31.69K	-89.78%31.69K	-74.60%69.82K	-67.05%310.1K	--310.1K	-59.06%274.9K	-53.27%296.59K	-45.22%265.84K	20.73%941.08K
-Taxes receivable	--10.42K	----	----	----	----	----	----	----	----	----
Inventory	--77.44K	31.89%123.75K	31.89%123.75K	41.69%184.35K	-32.90%93.82K	--93.82K	-11.79%130.11K	57.56%155.75K	18.63%129.71K	13.38%139.83K
Prepaid assets	--74.35K	-68.09%65.13K	-68.09%65.13K	11.67%76.21K	169.84%204.11K	--204.11K	-7.85%68.24K	-67.96%41.54K	-17.99%147.52K	-48.44%75.64K
Restricted cash	--44.85K	0.00%44.85K	0.00%44.85K	0.00%44.85K	0.00%44.85K	--44.85K	--44.85K	----	--44.85K	--44.85K
Total current assets	--474.81K	-51.74%435.61K	-51.74%435.61K	-62.00%487.26K	-74.88%902.69K	--902.69K	-66.06%1.28M	-58.15%1.88M	-31.27%2.83M	29.79%3.59M
Non current assets
Net PPE	--617.53K	-17.52%650.61K	-17.52%650.61K	-16.88%684.53K	225.54%788.77K	--788.77K	201.03%823.59K	-41.11%178.96K	-36.96%210.63K	-33.85%242.3K
-Gross PPE	--1.27M	0.00%1.31M	0.00%1.31M	2.81%1.31M	106.98%1.31M	--1.31M	88.71%1.27M	-11.04%598.11K	-10.51%599.84K	-6.18%632.17K
-Accumulated depreciation	---647.58K	-26.59%-657.86K	-26.59%-657.86K	-38.93%-623.94K	-33.30%-519.7K	---519.7K	-12.05%-449.09K	-13.76%-419.15K	-15.78%-389.21K	-26.79%-389.87K
Non current note receivables	----	----	----	----	----	----	10.80%566.76K	--528.91K	--509.26K	--512.84K
Total non current assets	--617.53K	-17.52%650.61K	-17.52%650.61K	-50.77%684.53K	4.45%788.77K	--788.77K	67.54%1.39M	105.90%707.87K	94.95%719.89K	106.16%755.14K
Total assets	--1.09M	-35.78%1.09M	-35.78%1.09M	-56.16%1.17M	-61.10%1.69M	--1.69M	-42.01%2.67M	-46.48%2.59M	-20.87%3.55M	38.71%4.35M
Liabilities
Current liabilities
Current debt and capital lease obligation	--5.12M	114.45%4.48M	114.45%4.48M	61.34%3.48M	0.52%2.09M	--2.09M	6.69%2.15M	1,344.38%2.15M	1,343.54%2.14M	1,311.87%2.08M
-Current debt	--5.01M	118.50%4.37M	118.50%4.37M	68.50%3.37M	3.77%2M	--2M	7.01%2M	--2M	--1.99M	--1.93M
-Current capital lease obligation	--113.79K	23.61%110.19K	23.61%110.19K	-31.63%105.26K	-40.92%89.14K	--89.14K	2.66%153.95K	2.47%152.72K	2.48%151.8K	2.50%150.88K
Payables	--338.79K	209.95%274.23K	209.95%274.23K	325.35%495.57K	-43.69%88.48K	--88.48K	-35.27%116.51K	-58.31%95.8K	18.34%278.28K	-2.34%157.11K
-accounts payable	--338.79K	209.95%274.23K	209.95%274.23K	325.35%495.57K	-43.69%88.48K	--88.48K	-35.27%116.51K	-58.31%95.8K	18.34%278.28K	-2.34%157.11K
Current accrued expenses	--29.06K	-78.98%42.06K	-78.98%42.06K	99.20%175.54K	-9.72%200.11K	--200.11K	-52.95%88.12K	169.25%167.15K	33.25%168.18K	190.69%221.67K
Current liabilities	--5.49M	101.73%4.8M	101.73%4.8M	75.80%4.15M	-3.23%2.38M	--2.38M	-1.16%2.36M	447.87%2.42M	407.29%2.58M	539.32%2.46M
Non current liabilities
Long term debt and capital lease obligation	--553.37K	-15.88%583.59K	-15.88%583.59K	-9.70%612.23K	580.29%693.78K	--693.78K	408.90%677.96K	-98.17%36.05K	-96.43%69.39K	-95.31%101.98K
-Long term debt	----	----	----	----	----	----	15.00%28.96K	-98.47%27.96K	-98.48%27K	-98.68%26.09K
-Long term capital lease obligation	--553.37K	-15.88%583.59K	-15.88%583.59K	-5.67%612.23K	814.13%693.78K	--693.78K	500.72%649K	-94.18%8.09K	-75.00%42.38K	-61.91%75.9K
Total non current liabilities	--553.37K	-15.88%583.59K	-15.88%583.59K	-9.70%612.23K	580.29%693.78K	--693.78K	408.90%677.96K	-98.17%36.05K	-96.43%69.39K	-95.31%101.98K
Total liabilities	--6.04M	75.16%5.38M	75.16%5.38M	56.71%4.76M	20.03%3.07M	--3.07M	20.53%3.04M	1.80%2.45M	8.29%2.65M	-0.07%2.56M
Shareholders'equity
Share capital	--23.99M	0.00%23.99M	0.00%23.99M	0.00%23.99M	0.00%23.99M	--23.99M	0.00%23.99M	0.00%23.99M	3.56%23.99M	13.31%23.99M
-common stock	--23.99M	0.00%23.99M	0.00%23.99M	0.00%23.99M	0.00%23.99M	--23.99M	0.00%23.99M	0.00%23.99M	3.56%23.99M	13.31%23.99M
Retained earnings	---33.35M	-9.98%-32.68M	-9.98%-32.68M	-11.39%-31.97M	-12.11%-29.72M	---29.72M	-9.61%-28.7M	-9.29%-28.2M	-8.31%-27.43M	-7.33%-26.51M
Gains losses not affecting retained earnings	--4.41M	1.17%4.4M	1.17%4.4M	1.07%4.39M	0.95%4.35M	--4.35M	1.49%4.34M	2.53%4.34M	3.37%4.33M	5.02%4.31M
Total stockholders'equity	---4.95M	-211.14%-4.29M	-211.14%-4.29M	-885.96%-3.59M	-177.14%-1.38M	---1.38M	-117.41%-363.79K	-94.40%135.93K	-56.08%891.83K	211.71%1.79M
Total equity	---4.95M	-211.14%-4.29M	-211.14%-4.29M	-885.96%-3.59M	-177.14%-1.38M	---1.38M	-117.41%-363.79K	-94.40%135.93K	-56.08%891.83K	211.71%1.79M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

AQS Aequus Pharmaceuticals Inc

Aequus Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow